Scholarlink

<p>Extra-large HDL molecules (average diameter 14.3 nm) were inversely associated with preeclampsia. Additionally, extremely (particle diameters from 75 nm upwards) and very large (average diameter 64 nm) VLDL metabolites were associated with an increased the risk of preeclampsia. These findings provide evidence of molecules of interest for establishing risk or developing potential therapeutic targets" to "Specifically, extra-large HDL molecules (average diameter 14.3 nm) were inversely associated with preeclampsia, whereas extremely large (≥75 nm) and very large (average diameter 64 nm) VLDL metabolites were associated with an increased risk. These findings highlight distinct lipoprotein-related metabolic signatures linked to preeclampsia and suggest potential targets for risk assessment and therapeutic intervention.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Metabolomic profile associated with preeclampsia and its severity: a case-control study in Colombian pregnant women

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年8月27日

查看全文
  • Claudia C. Colmenares-Mejia,
  • Paula K. Bautista-Nino,
  • Doris C. Quintero-Lesmes,
  • Carlos Riaño,
  • Jose Maria Satizabal,
  • Jie Hu,
  • Kathryn J. Gray,
  • Norma C. Serrano

摘要

Extra-large HDL molecules (average diameter 14.3 nm) were inversely associated with preeclampsia. Additionally, extremely (particle diameters from 75 nm upwards) and very large (average diameter 64 nm) VLDL metabolites were associated with an increased the risk of preeclampsia. These findings provide evidence of molecules of interest for establishing risk or developing potential therapeutic targets" to "Specifically, extra-large HDL molecules (average diameter 14.3 nm) were inversely associated with preeclampsia, whereas extremely large (≥75 nm) and very large (average diameter 64 nm) VLDL metabolites were associated with an increased risk. These findings highlight distinct lipoprotein-related metabolic signatures linked to preeclampsia and suggest potential targets for risk assessment and therapeutic intervention.